symbol,statement_type,period_end,line_item,value
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,96610000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-79204000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,End Cash Position,888992000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,774099000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,114893000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-21301000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-104838000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-38008000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,121545000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,40434000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,81111000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-39620000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,1000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,35886000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,2643000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,2643000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-78150000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,1054000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-79204000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,175814000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-10839000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-349529000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,632172000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-24702000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Change In Payable,361874000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-1077068000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-241805000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,65648000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,-5403000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,38161000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Depreciation,38161000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,5063000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,10354000.0
NATHBIOGEN.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,405844000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,478181000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-267757000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,End Cash Position,774099000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,379952000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,394146000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-77780000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-1000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-91112000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-38008000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,51340000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,27102000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,24238000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-274012000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,1000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,3224000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-9980000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-9980000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,0.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,0.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-267256000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,501000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-267757000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,745938000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-3403000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,230949000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,288208000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-11254000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Change In Payable,155606000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-224625000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,23014000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,97165000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,-34488000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,32612000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,16056000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Depreciation,32612000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,5065000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-10000.0
NATHBIOGEN.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,415647000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,358178000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-25488000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,End Cash Position,379952000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,41806000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,338147000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-16679000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-101208000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-38008000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,122537000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,125153000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-2616000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-28840000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,-4000000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,179000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-2000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-2000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,-675000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,-675000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-24342000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,471000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-24813000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,383666000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-9221000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-98132000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,257929000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-3926000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-150461000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,124962000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-326636000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,101235000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,0.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,30123000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,16409000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Depreciation,13714000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,-3164000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,12000.0
NATHBIOGEN.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,361643000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,159311000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-11166000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,End Cash Position,41806000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-14000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,292161000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-250355000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-222320000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,240000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-106110000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-38008000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-78202000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-78322000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,120000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-198512000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,-199000000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,10926000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-3000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-3000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-130000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-130000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-10305000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,731000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-11036000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,170477000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-28774000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-189270000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,125535000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-2193000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Change In Payable,199922000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,59571000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-572105000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,93477000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,887819000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,30841000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,16055000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Depreciation,14786000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,6259000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-36000.0
NATHBIOGEN.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,-634337000.0
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,-1.0
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,-502000.0
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,-516000.0
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,-516000.0
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Depreciation,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
NATHBIOGEN.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
